Published • loading... • Updated
Beckman Coulter Receives CE Mark for Automated p-Tau217 Alzheimer’s Blood Test
Summary by Clinical Lab Products
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Beckman Coulter Receives CE Mark for Automated p-Tau217 Alzheimer’s Blood Test
The p-Tau217 assay runs on the DxI 9000 Immunoassay Analyzer, enabling laboratories to incorporate blood-based Alzheimer’s biomarker testing into high-throughput workflows. Beckman Coulter Diagnostics has received CE Mark under In Vitro Diagnostic Regulation for its Access p-Tau217 assay, a blood-based test designed to support the clinical evaluation of amyloid pathology in patients with signs and symptoms of cognitive decline. The company will …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
